Efstathios J. Boviatsis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Efstathios J. Boviatsis has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Andreas T. Kouyialis
University of Athens Medical School, Evangelismos General Hospital
5 shared publicationsDamianos E. Sakas
University of Athens Medical School, Evangelismos General Hospital
5 shared publications- Damianos Sakas Athens
Department of Neurosurgery, University of Athens Medical School, Evangelismos Hospital, Athens, Greece
2 shared publications - Lampis C. Stavrinou
Petros S. Kokkalis' Hellenic Center for Neurosurgical Research, Athens, Greece
2 shared publications Maria M. Gavra
‘‘Ag. Sofia’’ Children’s Hospital
2 shared publicationsMarios Themistokleous
University of Athens Medical School, Evangelismos General Hospital
2 shared publications
Latest Publications
- Open Access
- 29 September 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (10) , 1231
Emerging Role of the Slit/Roundabout (Robo) Signaling Pathway in Glioma Pathogenesis and Potential Therapeutic Options
Gliomas represent the most common primary Central Nervous System (CNS) tumors, characterized by increased heterogeneity, dysregulated intracellular signaling, extremely invasive properties, and a dismal prognosis. They are generally resistant to existing therapies and only a few molecular targeting options are currently available. In search of signal transduction pathways with a potential impact in glioma growth and immunotherapy, the Slit guidance ligands (Slits) and their Roundabout (Robo) family of receptors have been revealed as key regulators of tumor cells and their microenvironment. Recent evidence indicates the implication of the Slit/Robo signaling pathway in inflammation, cell migration, angiogenesis, and immune cell infiltration of gliomas, suppressing or promoting the expression of pivotal proteins, such as cell adhesion molecules, matrix metalloproteinases, interleukins, angiogenic growth factors, and immune checkpoints. Herein, we discuss recent data on the significant implication of the Slit/Robo signaling pathway in glioma pathology along with the respective targeting options, including immunotherapy, monoclonal antibody therapy, and protein expression modifiers.
- 29 September 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (10) , 1231
Open AccessEmerging Role of the Slit/Roundabout (Robo) Signaling Pathway in Glioma Pathogenesis and Potential Therapeutic Options
Gliomas represent the most common primary Central Nervous System (CNS) tumors, characterized by increased heterogeneity, dysregulated intracellular signaling, extremely invasive properties, and a dismal prognosis. They are generally resistant to existing therapies and only a few molecular targeting options are currently available. In search of signal transduction pathways with a potential impact in glioma growth and immunotherapy, the Slit guidance ligands (Slits) and their Roundabout (Robo) family of receptors have been revealed as key regulators of tumor cells and their microenvironment. Recent evidence indicates the implication of the Slit/Robo signaling pathway in inflammation, cell migration, angiogenesis, and immune cell infiltration of gliomas, suppressing or promoting the expression of pivotal proteins, such as cell adhesion molecules, matrix metalloproteinases, interleukins, angiogenic growth factors, and immune checkpoints. Herein, we discuss recent data on the significant implication of the Slit/Robo signaling pathway in glioma pathology along with the respective targeting options, including immunotherapy, monoclonal antibody therapy, and protein expression modifiers.
- Open Access
- 11 March 2016
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 21-9
Neuromuscular electrical stimulation acutely mobilizes endothelial progenitor cells in critically ill patients with sepsis
- 11 March 2016
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 21-9
Open AccessNeuromuscular electrical stimulation acutely mobilizes endothelial progenitor cells in critically ill patients with sepsis
- Open Access
- 7 June 2011
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 5 (1) , 217
Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
In rare instances, demyelinating disorders manifest as tumefactive lesions that simulate brain tumors. We report a patient with a space-occupying lesion in the parietal lobe, which presented a serious diagnostic dilemma, between a rare tumefactive demyelinating disease, such as Balo concentric sclerosis and a glioma. This case report highlights important diagnostic clues in the differential diagnosis of Balo concentric sclerosis.
- 7 June 2011
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 5 (1) , 217
Open AccessPitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
In rare instances, demyelinating disorders manifest as tumefactive lesions that simulate brain tumors. We report a patient with a space-occupying lesion in the parietal lobe, which presented a serious diagnostic dilemma, between a rare tumefactive demyelinating disease, such as Balo concentric sclerosis and a glioma. This case report highlights important diagnostic clues in the differential diagnosis of Balo concentric sclerosis.
- 15 May 2008
- Published by Springer Nature in European Spine Journal
- Vol. 17 (6) , 838
Spinal synovial cysts: pathogenesis, diagnosis and surgical treatment in a series of seven cases and literature review
- 15 May 2008
- Published by Springer Nature in European Spine Journal
- Vol. 17 (6) , 838
Spinal synovial cysts: pathogenesis, diagnosis and surgical treatment in a series of seven cases and literature review
- 4 April 2008
- Published by Springer Nature in European Spine Journal
- Vol. 17 (6) , 831-837
Spinal synovial cysts: pathogenesis, diagnosis and surgical treatment in a series of seven cases and literature review
This study is designed based on the retrospective analysis of patients treated in the Neurosurgical Department of two major hospitals and review of the literature. The aim of this study is to evaluate the efficacy of surgery and address controversial issues in the treatment of symptomatic lumbar intraspinal synovial cysts. Spinal juxtafacet cysts (synovial and ganglion cysts) are a rare cause of low back and radicular leg pain. Although the relevant reports in the international literature are increasing, the controversy about conservative versus surgical treatment and the need for concomitant fusion still exists. Data from seven patients (age range 58–69 years, mean age 61 years) with low back and radicular leg pain due to a lumbar facet joint cyst were retrospectively analyzed. Demographic data, cyst level, presence of concomitant local pathology, treatment and results of treatment were recorded. A follow-up of at least 6 months (range 6–48 months) was conducted and results were noted. All patients had back pain, while five also experienced unilateral radicular leg pain and one had bilateral leg pain. One patient had neurogenic claudication. MRI identified the cyst and highlighted underlying pathology in all cases. All patients underwent surgical cyst excision. No fusion was performed. Post-operatively, all patients showed a total resolution of symptoms with sustained benefit at final evaluation. Review of the literature revealed a trend towards surgery, as this is correlated to a more favorable outcome compared with conservative treatment. Fusion should be performed on a case-by-case basis only. Surgery is a safe and effective treatment choice in this increasingly appearing ailment. A prospective, randomized trial should clarify issues under debate.
- 4 April 2008
- Published by Springer Nature in European Spine Journal
- Vol. 17 (6) , 831-837
Spinal synovial cysts: pathogenesis, diagnosis and surgical treatment in a series of seven cases and literature review
This study is designed based on the retrospective analysis of patients treated in the Neurosurgical Department of two major hospitals and review of the literature. The aim of this study is to evaluate the efficacy of surgery and address controversial issues in the treatment of symptomatic lumbar intraspinal synovial cysts. Spinal juxtafacet cysts (synovial and ganglion cysts) are a rare cause of low back and radicular leg pain. Although the relevant reports in the international literature are increasing, the controversy about conservative versus surgical treatment and the need for concomitant fusion still exists. Data from seven patients (age range 58–69 years, mean age 61 years) with low back and radicular leg pain due to a lumbar facet joint cyst were retrospectively analyzed. Demographic data, cyst level, presence of concomitant local pathology, treatment and results of treatment were recorded. A follow-up of at least 6 months (range 6–48 months) was conducted and results were noted. All patients had back pain, while five also experienced unilateral radicular leg pain and one had bilateral leg pain. One patient had neurogenic claudication. MRI identified the cyst and highlighted underlying pathology in all cases. All patients underwent surgical cyst excision. No fusion was performed. Post-operatively, all patients showed a total resolution of symptoms with sustained benefit at final evaluation. Review of the literature revealed a trend towards surgery, as this is correlated to a more favorable outcome compared with conservative treatment. Fusion should be performed on a case-by-case basis only. Surgery is a safe and effective treatment choice in this increasingly appearing ailment. A prospective, randomized trial should clarify issues under debate.
- 1 October 2007
- Published by Elsevier in Surgical Neurology
- Vol. 68 (4) , 407-411
Impact of age on complications and outcome in meningioma surgery
- 1 October 2007
- Published by Elsevier in Surgical Neurology
- Vol. 68 (4) , 407-411
Impact of age on complications and outcome in meningioma surgery
- 30 June 2005
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 107 (4) , 289-295
Functional outcome of intrathecal baclofen administration for severe spasticity
- 30 June 2005
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 107 (4) , 289-295
Functional outcome of intrathecal baclofen administration for severe spasticity
- 1 October 2004
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 173 (4) , 217-218
Epidural haematoma after evacuation of contralateral subdural haematoma
- 1 October 2004
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 173 (4) , 217-218
Epidural haematoma after evacuation of contralateral subdural haematoma
- 1 May 2004
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 146 (5) , 463-467
Infected CNS infusion pumps. Is there a chance for treatment without removal?
Background. Intrathecal baclofen administration by means of an implantable pump is nowadays a safe and effective method in the treatment of spasticity. One of the rare but devastating complications of this technique is pump infection, with a variety of Gram (−) and Gram (+) organisms being involved. Treatment of these infections, according to international literature, requires removal of the device and appropriate antibiotic therapy. Method. This article reports the authors experience in treating 3 patients with severe, medically intractable spasticity, suffering from infection of the intrathecally-delivering pump. A decision was made not to replace the device, but to treat this complication with pump disinfection and with a new treatment modality that has never been used before, the intra-pocket administration of antibiotics. Findings. In all cases the infection was eradicated and the integrity of the pump maintained. None of the patients required a procedure under general anesthesia. Conclusions. Removal should no longer be considered the first treatment option in infections of intrathecally delivering pumps, especially those due to non-adherent bacteria, with mild clinical symptomatology. An initial attempt should always be made for conservative treatment. Intra-pocket administration of antibiotics helps in achieving high drugs levels locally, and may prove an important element in our armamentarium against such infections.
- 1 May 2004
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 146 (5) , 463-467
Infected CNS infusion pumps. Is there a chance for treatment without removal?
Background. Intrathecal baclofen administration by means of an implantable pump is nowadays a safe and effective method in the treatment of spasticity. One of the rare but devastating complications of this technique is pump infection, with a variety of Gram (−) and Gram (+) organisms being involved. Treatment of these infections, according to international literature, requires removal of the device and appropriate antibiotic therapy. Method. This article reports the authors experience in treating 3 patients with severe, medically intractable spasticity, suffering from infection of the intrathecally-delivering pump. A decision was made not to replace the device, but to treat this complication with pump disinfection and with a new treatment modality that has never been used before, the intra-pocket administration of antibiotics. Findings. In all cases the infection was eradicated and the integrity of the pump maintained. None of the patients required a procedure under general anesthesia. Conclusions. Removal should no longer be considered the first treatment option in infections of intrathecally delivering pumps, especially those due to non-adherent bacteria, with mild clinical symptomatology. An initial attempt should always be made for conservative treatment. Intra-pocket administration of antibiotics helps in achieving high drugs levels locally, and may prove an important element in our armamentarium against such infections.